| Date | Time | Source | | | 05/06/2013 | 9:30AM | PRNUS | MELA Sciences, Inc. Rings NASDAQ Opening Bell With Leading Dermatologists To Raise Awareness For Melanoma Detection And Preve...
MELA Sciences, Inc. Rings NASDAQ Opening Bell With Leading Dermatologists To Raise Awareness For Melanoma Detection And Prevention PR Newswire IRVINGTON, N.Y., May 6, 2013 IRVINGTON, N.Y., May 6, 2013 /PRNewswire/ -- In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention Month™... More...>> |
| 05/03/2013 | 10:00AM | GLOBE | MELA Sciences, Inc. [MELA] to Ring The NASDAQ Stock Market Opening Bell
ADVISORY, May 3, 2013 (GLOBE NEWSWIRE) -- What: MELA Sciences, Inc. [MELA], a medical device company focused on the commercialization of its flagship product, MelaFind®, will visit the NASDAQ MarketSite in Times Square. MelaFind® is the first and only FDA-approved diagnostic tool that is 100% objective and uses multi-spectral... More...>> |
| 04/30/2013 | 4:01PM | GLOBE | MELA Sciences Announces First Quarter 2013 Financial Results
IRVINGTON, N.Y., April 30, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, today announced financial results for the first quarter ended March 31, 2013. First Quarter 2013 Performance Highlights: Ended the first twelve months of... More...>> |
| 04/23/2013 | 8:00AM | PRNUS | MELA Sciences, Inc. Partners With Dermatologists Nationwide To Promote Skin Cancer Awareness
MELA Sciences, Inc. Partners With Dermatologists Nationwide To Promote Skin Cancer Awareness FREE MELAFIND® SESSIONS ON MAY 1 PR Newswire IRVINGTON, N.Y., April 23, 2013 IRVINGTON, N.Y., April 23, 2013 /PRNewswire/ -- MELA Sciences, Inc. (NASDAQ: MELA). (Logo: http://photos.prnewswire.com/prnh/20130103/NY36051LOGO... More...>> |
| 04/18/2013 | 4:05PM | GLOBE | MELA Sciences to Host Investor Meeting in Conjunction With Melanoma Monday on May 6th 2013 in New York
IRVINGTON, N.Y., April 18, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed MelaFind®, today announced that it will be hosting a meeting for investors and analysts in conjunction with Melanoma Monday on May 6, 2013 from 10:00am to 11:00am Eastern time, in New York... More...>> |
| 04/15/2013 | 4:05PM | GLOBE | MELA Sciences to Participate in Upcoming 12th Annual Needham Healthcare Conference
IRVINGTON, N.Y., April 15, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercizlizing MelaFind®, today announced that it will be participating in the upcoming Needham Growth Conference, being held April 30 – May 1, 2013 at the Westin Grand Central... More...>> |
| 04/10/2013 | 4:05PM | GLOBE | MELA Sciences to Release First Quarter 2013 Financial Results and Host Conference Call on Tuesday, April 30, 2013
IRVINGTON, N.Y., April 10, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, today announced that it will release its 2013 first quarter financial results after the close of trading on Tuesday, April 30, 2013. MELA Sciences executives... More...>> |
| 03/18/2013 | 9:15AM | PRNUS | MELA Sciences, Inc. Presents New Data That Reinforces The Importance Of MelaFind® As A Diagnostic Tool At AAD Meeting
MELA Sciences, Inc. Presents New Data That Reinforces The Importance Of MelaFind® As A Diagnostic Tool At AAD Meeting Data Shows that MelaFind® Significantly Improves Melanoma Detection Rates of Resident Dermatologists PR Newswire IRVINGTON, N.Y., March 18, 2013 IRVINGTON, N.Y., March 18, 2013 /PRNewswire/ -- Research... More...>> |
| 03/05/2013 | 4:02PM | GLOBE | MELA Sciences Announces Fourth Quarter and Year End 2012 Financial Results
IRVINGTON, N.Y., March 5, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, today announced financial results for the fourth quarter and year ended December 31, 2012. Fourth Quarter 2012 Performance Highlights: Accelerated our rate... More...>> |
| 02/21/2013 | 7:30AM | PRNUS | Epidemic Increases In Melanoma Rates Three Of Four Americans Surveyed Have Never Had Skin Cancer Examination
Epidemic Increases In Melanoma Rates Three Of Four Americans Surveyed Have Never Had Skin Cancer Examination Survey Commissioned by MELA Sciences, Inc. Illustrates Need to Expand Skin Cancer Detection Habits in U.S. PR Newswire IRVINGTON, N.Y., Feb. 21, 2013 IRVINGTON, N.Y., Feb. 21, 2013 /PRNewswire/ -- MELA Sciences... More...>> |
| 02/12/2013 | 8:15AM | GLOBE | MELA Sciences Prices Public Offering of Common Stock; Termination of At the Market (ATM) Equity Offering Program; and Execution
IRVINGTON, N.Y., Feb. 12, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company focused on the design, development and commercialization of MelaFind®, today announced the pricing of an underwritten offering of 6,100,000 shares of its common stock at an offering price of $1.30 per share... More...>> |
| 02/04/2013 | 8:00AM | GLOBE | MELA Sciences to Release Fourth Quarter and Year End 2012 Financial Results and Host Conference Call on Tuesday, March 5, 2013
IRVINGTON, N.Y., Feb. 4, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, today announced that it will release its 2012 fourth quarter and year-end financial results after the close of trading on Tuesday, March 5, 2013. MELA Sciences... More...>> |
| 01/31/2013 | 8:00AM | PRNUS | Free Research Report on Lloyds Banking Group plc, MELA Sciences, Inc., Mentor Graphics Corp., Mizuho Financial Group Inc. and...
Free Research Report on Lloyds Banking Group plc, MELA Sciences, Inc., Mentor Graphics Corp., Mizuho Financial Group Inc. and Manitex International, Inc. Free Research Report on Lloyds Banking Group plc, MELA Sciences, Inc., Mentor Graphics Corp., Mizuho Financial Group Inc. and Manitex International, Inc. PR Newswire... More...>> |
| 01/28/2013 | 8:45AM | GLOBE | MELA Sciences to Present at Upcoming Investor Conferences
IRVINGTON, N.Y., Jan. 28, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company focused on the design, development and commercialization of MelaFind®, today announced that Joseph V. Gulfo, MD, President and CEO, will be participating at three upcoming investor conferences. On Thursday... More...>> |
| 01/04/2013 | 8:00AM | PRNUS | MELA Sciences to Participate in Upcoming 15th Annual Needham Growth Conference
MELA Sciences to Participate in Upcoming 15th Annual Needham Growth Conference /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:8pt; font-family:"Arial"; color:black;... More...>> |
| 01/03/2013 | 8:00AM | PRNUS | MELA Sciences Names Rpr Marketing Communications as its New Agency of Record
MELA Sciences Names Rpr Marketing Communications as its New Agency of Record /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:8pt; font-family:"Arial"; color:black;... More...>> |
| 11/09/2012 | 12:03PM | GLOBE | MELA Sciences to Participate in Upcoming Stephens Fall Investor Conference
IRVINGTON, N.Y., Nov. 9, 2012 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed MelaFind®, today announced that it will be participating in the upcoming Stephens Fall Investor Conference, being held November 13 – 14, 2012 in New York. Joseph V. Gulfo, MD, MELA Sciences... More...>> |
| 11/07/2012 | 4:05PM | GLOBE | MELA Sciences Announces Third Quarter 2012 Financial Results
IRVINGTON, N.Y., Nov. 7, 2012 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, today announced financial results for the third quarter ended September 30, 2012. Third Quarter 2012 Performance Highlights: Accelerated our rate of signed... More...>> |
| 11/05/2012 | 7:00AM | GLOBE | MelaFind Chosen as One of Top 10 Medical Innovations for 2013 by Cleveland Clinic
NEW YORK, Nov. 5, 2012 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed MelaFind®, a breakthrough device intended to help dermatologists detect melanoma when it is still curable, announced today that it has been included in the Top 10 Medical Innovations for 2013 compiled... More...>> |
| 10/24/2012 | 4:05PM | GLOBE | MELA Sciences to Release Third Quarter Financial Results and Host Conference Call on Wednesday, November 7, 2012
IRVINGTON, N.Y., Oct. 24, 2012 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, today announced that it will release its 2012 third quarter financial results after the close of trading on Wednesday, November 7, 2012. MELA Sciences executives... More...>> |
|
